Fund balancing drive sparks controversy in Germany
This article was originally published in Clinica
Executive Summary
Draft proposals by German health minister Ulla Schmidt to reform the financing of the statutory health insurance funds have come under sustained fire from the companies' sickness Fund (BKK). The confederation of German employers' associations, opposition parties and doctors' associations have also weighed in with their criticisms.
You may also be interested in...
Regulatory Blessings Helping China CAR-Ts March Closer To Global Cancer Patients?
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
Polpharma Pursues Tysabri Through Antelope Trial
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.
EU Guidance Document To Ensure Devices Are Assessed By Appropriately-Trained Reviewers
How do notified bodies ensure that their personnel, and the teams they allocate for conformity assessment of medical devices, have the precise knowledge and expertise needed? A new EU document gives guidance on this.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: